826 related articles for article (PubMed ID: 17658999)
1. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999
[TBL] [Abstract][Full Text] [Related]
2. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
Huttunen M; Harvima IT
Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
[TBL] [Abstract][Full Text] [Related]
3. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
[TBL] [Abstract][Full Text] [Related]
4. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro.
Diaconu NC; Rummukainen J; Naukkarinen A; Mättö M; Harvima RJ; Pelkonen J; Harvima IT
Arch Dermatol Res; 2011 Sep; 303(7):499-512. PubMed ID: 21274549
[TBL] [Abstract][Full Text] [Related]
5. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions.
Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M
Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625
[TBL] [Abstract][Full Text] [Related]
6. Mast cell tryptase and chymase in the progress of cutaneous vasculitis.
Lipitsä T; Naukkarinen A; Harvima IT
Arch Dermatol Res; 2015 Dec; 307(10):917-24. PubMed ID: 26498154
[TBL] [Abstract][Full Text] [Related]
7. Increase in CD30 ligand/CD153 and TNF-alpha expressing mast cells in basal cell carcinoma.
Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Nilsson G; Harvima IT
Cancer Immunol Immunother; 2007 Sep; 56(9):1407-15. PubMed ID: 17268792
[TBL] [Abstract][Full Text] [Related]
8. The production of collagen and the activity of mast-cell chymase increase in human skin after irradiation therapy.
Riekki R; Harvima IT; Jukkola A; Risteli J; Oikarinen A
Exp Dermatol; 2004 Jun; 13(6):364-71. PubMed ID: 15186323
[TBL] [Abstract][Full Text] [Related]
9. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
He SH; Chen P; Chen HQ
Acta Pharmacol Sin; 2003 Sep; 24(9):923-9. PubMed ID: 12956943
[TBL] [Abstract][Full Text] [Related]
10. Mast cells in diffuse large B-cell lymphoma; their role in fibrosis.
Fukushima H; Ohsawa M; Ikura Y; Naruko T; Sugama Y; Suekane T; Kitabayashi C; Inoue T; Hino M; Ueda M
Histopathology; 2006 Nov; 49(5):498-505. PubMed ID: 17064296
[TBL] [Abstract][Full Text] [Related]
11. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors.
Kaminska R; Naukkarinen A; Glinski W; Horsmanheimo M; Harvima IT
Acta Derm Venereol; 1999 Sep; 79(5):351-5. PubMed ID: 10494709
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of tryptase- and chymase-containing mast cells in cutaneous lichen planus.
Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M
Acta Derm Venereol; 1991; 71(5):394-8. PubMed ID: 1721758
[TBL] [Abstract][Full Text] [Related]
13. Mast cell tryptase and chymase in developing and mature psoriatic lesions.
Harvima IT; Naukkarinen A; Paukkonen K; Harvima RJ; Aalto ML; Schwartz LB; Horsmanheimo M
Arch Dermatol Res; 1993; 285(4):184-92. PubMed ID: 8342961
[TBL] [Abstract][Full Text] [Related]
14. Increased numbers of tryptase-positive mast cells in the healthy and sun-protected skin of tobacco smokers.
Kaukinen A; Fitzgibbon A; Oikarinen A; Hinkkanen L; Viinikanoja M; Harvima IT
Dermatology; 2014; 229(4):353-8. PubMed ID: 25376107
[TBL] [Abstract][Full Text] [Related]
15. Increased mast cell density and protease content in actinic cheilitis.
Rojas IG; Martínez A; Pineda A; Spencer ML; Jiménez M; Rudolph MI
J Oral Pathol Med; 2004 Oct; 33(9):567-73. PubMed ID: 15357678
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells.
Schwartz LB; Irani AM; Roller K; Castells MC; Schechter NM
J Immunol; 1987 Apr; 138(8):2611-5. PubMed ID: 3549903
[TBL] [Abstract][Full Text] [Related]
17. [Correlations between chymase activity, levels of tryptase, and eotaxin in the sputum of patients with chronic obstructive pulmonary disease and their clinical implications].
Zhang XJ; He SH; Xie H; Wei JF; Liu CT
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):649-53. PubMed ID: 16200864
[TBL] [Abstract][Full Text] [Related]
18. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.
Ibaraki T; Muramatsu M; Takai S; Jin D; Maruyama H; Orino T; Katsumata T; Miyazaki M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):617-21. PubMed ID: 16125954
[TBL] [Abstract][Full Text] [Related]
19. Mast cells in melanocytic skin lesions. An immunohistochemical and quantitative study.
Dyduch G; Okoń K; Pescarini E
Pol J Pathol; 2011 Sep; 62(3):139-44. PubMed ID: 22102069
[TBL] [Abstract][Full Text] [Related]
20. Increased mast cell expression of PAR-2 in skin inflammatory diseases and release of IL-8 upon PAR-2 activation.
Carvalho RF; Nilsson G; Harvima IT
Exp Dermatol; 2010 Feb; 19(2):117-22. PubMed ID: 19889021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]